Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
Improving and optimising human resources for health, infrastructure building, trauma care and prevention and management of lifestyle diseases are some of the thrust areas identified for the State’s health sector when the 12th Plan is implemented. There would be no scarcity of resources for health sector in the 12th Plan …
Increasing the heat on Chinese drug firms exporting medicines to India, the Drug Controller General of India (DCGI) is all set to open its first foreign drug inspection office in Beijing by March 1. Around four Indian drug inspectors will be posted in China to inspect manufacturing sites and check …
Analysts say the new mechanism would impact revenues in the short term only The Indian pharmaceutical industry is likely to see a dip in valuations in the near term as a result of the recent pricing policy that aims to intensify the regulatory hold over essential drugs. Profit of major …
India’s vaccine manufacturing sector is set for massive export boost with the country’s national regulatory authority, the Central Drugs Standard Control Organisation (CDSCO), passing the WHO’s toughest efficacy and safety tests. An 18-member team of drug inspectors from the WHO, US-FDA, Sweden, China, Switzerland and Thailand reviewed the Central Drug …
The malaria burden is concentrated in 14 endemic countries, which account for an estimated 80% of malaria deaths and India is the most affected country in South-East Asia, reveals this World Malaria Report 2012 released recently. The World Malaria Report 2012 summarizes information received from 104 malaria-endemic countries and other …
The programme was started at six centres in Tamil Nadu The Chennai-based National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre) has started a pilot testing programme of providing for six months isoniazid TB drug as prophylactic to HIV-positive individuals. People recruited will include those on antiretroviral therapy (ART) …
The Supreme Court Wednesday asked the Centre to place before it their gazette notification over the new drug policy. A Bench led by Justice G S Singhvi gave the Centre time till January 15 to put on record the National Pharmaceutical Pricing Policy so that the court could examine it …
Months after the Union Health Ministry turned down demands of a section of the medical community to devise ways to fight Totally Drug Resistant (TDR) Tuberculosis, an article in the latest issue of Indian Journal of Medical Research (IJMR) has underscored the need for such a move, at least for …
Prices of drugs that are defined as essential under the existing policy, but will not remain so under the new pharma pricing policy, would be frozen for a year, after which pharmaceutical firms would be allowed to increase prices at the rate of not more than 10% every year. For …
In a bid to ensure that the drugs available in the country are safe for consumption, the Drug Controller-General of India (DCGI) has asked the state drug inspectors to get the samples of the drugs collected and get them tested for their quality at the drug testing laboratories. The issue …
India will soon have a scientific regulatory agency responsible for the safety of the nation’s domestically produced and imported foods, cosmetics, drugs, biologics, medical devices, and radiological products. Proposed on the lines of Centre for Food Safety and Applied Nutrition in USA and the Centre for Disease Control, the new …
A study published in the Malaria World Journal has found that worldwide 2.6 per cent of all WHO-approved artemisinin-based anti-malaria drugs are substandard, as they have less than the prescribed quantity of active ingredient. For India, the figure stands at 4 per cent while in China it is 12.3 per …
A massive 15-year-long international study, with significant contribution from Indian doctors has found that the most common drug against breast cancer — Tamoxifen, used in women with ERpositive (oestrogen receptor-positive) breast cancer, significantly cuts deaths and also reduces recurrence of the cancer, if taken for a decade rather than for …
The government has finalised the National Pharmaceuticals Pricing Policy 2012, which would replace the Drugs (Price Control) Order, 1994 that currently monitors and regulates prices of essential medicines in the country. The National Pharmaceuticals Pricing Policy, 2012 seeks to regulate drug prices on the basis of essentiality of the drug …
Chennai Declaration lists out ways to tackle the global challenge India needs to take urgent initiatives to formulate an effective national policy to control the rising trend of antimicrobial resistance, including a ban on over-the-counter sale of antibiotics, and changes in the medical education curriculum to include training on antibiotic …
India on Friday announced that 91 important drugs — 73 antibiotics, 13 habit-forming drugs and 4 anti-TB drugs are being brought under a new schedule H1 in the country’s Drugs and Cosmetics Rules which will ban its over-the-counter sale besides having warning boxes that read “dangerous to take this preparation …
An Indian-origin scientist is developing new vaccine pills from tiny pollen particles, which could treat people suffering from sneezing allergy. Harvinder Gill, a chemical engineer at Texas Tech University, plans to scoop out the pollen’s allergycausing innards and leave just the non-allergenic outer shell. The idea harnesses the power of …
The union government on Friday said that a vaccine against the deadly dengue is being developed and expressed optimism that the trials would be successful. Responding to the call attention motion on the subject raised by Opposition members, Union health minister Ghulam Nabi Azad said that the trials of the …
Sandoz, the generic arm of Swiss drug maker Novartis, has decided to shut its facility for development of generic drugs in India. The facility, known as Sandoz Development Centre located near Mumbai, employed around 157 people, who are now given notice till February, sources, close to the development, told Business …
